We are live on ! Find out more
MURA

Mural Oncology
MURA

Delisted

MURA was delisted on the 4th of December, 2025.

Back to rankings

123 hedge funds and large institutions have $79.7M invested in Mural Oncology in 2023 Q4 according to their latest regulatory filings, with 123 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

80.7% more ownership

Funds ownership: 0% → 80.7% (+81%)

Holders
123
Holders Change
+123
Holders Change %
–
% of All Funds
1.79%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
123
Increased
–
Reduced
–
Closed
–
Calls
$12K
Puts
–
Net Calls
+$12K
Net Calls Change
+$12K

Top Buyers

Rank Fund Capital Flow
1
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$7.98M
2
AC
Armistice Capital
New York
+$6.67M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$6.13M
4
BlackRock
BlackRock
New York
+$4.72M
5
AFA
Alta Fundamental Advisers
New York
+$2.41M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Westfield Capital Management
1
Westfield Capital Management
Massachusetts
$11.8M +$7.98M +1,985,886 New
AC
2
Armistice Capital
New York
$9.82M +$6.67M +1,658,000 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$9.02M +$6.13M +1,524,017 New
BlackRock
4
BlackRock
New York
$6.94M +$4.72M +1,173,007 New
AFA
5
Alta Fundamental Advisers
New York
$3.55M +$2.41M +600,000 New
NM
6
Newtyn Management
New York
$2.63M +$1.79M +445,000 New
PM
7
Prosight Management
Texas
$2.48M +$1.68M +418,505 New
Bank of New York Mellon
8
Bank of New York Mellon
New York
$2.36M +$1.61M +399,462 New
State Street
9
State Street
Massachusetts
$2.24M +$1.52M +377,586 New
Geode Capital Management
10
Geode Capital Management
Massachusetts
$2.11M +$1.43M +356,367 New
Pictet Asset Management
11
Pictet Asset Management
Switzerland
$1.67M +$1.13M +281,955 New
Primecap Management
12
Primecap Management
California
$1.52M +$1.03M +256,255 New
Citadel Advisors
13
Citadel Advisors
Florida
$1.47M +$998K +248,182 New
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$1.41M +$959K +238,482 New
Squarepoint
15
Squarepoint
New York
$1.4M +$949K +235,985 New
Millennium Management
16
Millennium Management
New York
$1.31M +$890K +221,441 New
Morgan Stanley
17
Morgan Stanley
New York
$1.31M +$890K +221,366 New
HF
18
HRT Financial
New York
$1.2M +$812K +201,934 New
Artisan Partners
19
Artisan Partners
Wisconsin
$1.1M +$746K +185,432 New
Norges Bank
20
Norges Bank
Norway
$998K +$678K +168,511 New
Northern Trust
21
Northern Trust
Illinois
$956K +$649K +161,402 New
Verition Fund Management
22
Verition Fund Management
Connecticut
$938K +$637K +158,387 New
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$846K +$574K +142,846 New
Goldman Sachs
24
Goldman Sachs
New York
$747K +$507K +126,208 New
CC
25
Centiva Capital
New York
$592K +$402K +100,000 New
1
2 3 4 5

MURA Hedge Fund Activity: Q4 2023 in Review

123 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Mural Oncology (MURA) for Q4 2023, worth a combined $79.7M.

Buyers outnumbered sellers: 123 funds opened new MURA positions and 0 closed out — a net gain of 123 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Westfield Capital Management, opening a new position worth an estimated $7.98M.

  • 123 institutional investors held Mural Oncology (MURA) as of Q4 2023, up from 0 in Q3 2023.
  • Funds reported $79.7M of Mural Oncology stock for Q4 2023.
  • 123 funds opened new Mural Oncology positions in Q4 2023 and 0 closed out, a net change of +123 holders.
  • The largest Mural Oncology buyer in Q4 2023 was Westfield Capital Management, an estimated $7.98M added.

Based on aggregated 13F filings for Q4 2023.